Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: The Kansas Department of Health and Environment announced Thursday that students entering kindergarten and first grade will need two doses of a hepatitis A vaccine. Students entering seventh grade will need one dose of the meningococcal ACWY vaccine. And students starting their junior year will need the meningococcal ACWY vaccine if they have not been vaccinated before their 16th birthday. The new requirements take effect Aug. 2. Kansas allows exemptions from vaccines only for medical and religious reasons. Health department Secretary Lee Norman said the agency collected public input before proposing the new requirements. He said meningitis and hepatitis A are both severe diseases that are preventable with vaccines.
[EX A]: 2 new vaccines required for some Kansas school students.

[EX Q]: One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for interfering with heart-harmful genes without modifying the genes themselves — in one case, with treatment just twice a year. The research was featured at an American Heart Association conference ending Monday in Philadelphia. “There’s a lot of excitement” about the new gene-targeting medicines, especially because they seem to last so long, said Dr. Karol Watson, of the University of California, Los Angeles. Scientists have been exploring gene therapy — altering DNA — to attack the root cause of many diseases. The new drugs essentially accomplish the same thing without tampering with genes, said the University of Pennsylvania’s Dr. Daniel Rader, who has consulted for some makers of these drugs. The medicines work by silencing or blocking messages that genes give to cells to make proteins that can do harm, such as allowing cholesterol to accumulate. The first few of these “RNA-interference” drugs recently were approved for other conditions, and research is also targeting heart disease. Farthest along is inclisiran, tested in 1,561 people with heart disease from clogged arteries who still had high LDL, the bad form of cholesterol, despite taking standard drugs. They were given a shot of inclisiran or a dummy drug when they joined the study, three months later and then every six months. The drug lowered LDL by 56% without serious side effects. More testing will show whether it also lowers heart attacks and other problems, not just cholesterol. Inclisiran’s maker, The Medicines Company, plans to seek federal approval for it later this year. Two other RNA interference drugs aim at a different target — triglycerides, another fat in the blood that’s elevated in one quarter of Americans. Treatments include very low-fat diets, weight loss, fish oil and drugs, but doctors say more and better therapies are needed. Each RNA interference drug was tested at various doses in 40 people. A single shot lowered triglycerides by 30% to 67%, and the benefit lasted for at least four months. The studies were just intended to show safety; Arrowhead Pharmaceuticals is developing both drugs. Other research found new benefits from older drugs. AstraZeneca’s Farxiga, originally developed to treat diabetes, also lowered the risk of heart problems in heart failure patients who did not have diabetes. Among 2,605 of such patients treated for 18 months, about 9% of those on Farxiga had worsening heart failure or heart-related death versus nearly 13% of those not given the drug. That worked out to a 27% lower risk, without extra serious side effects. Surprising benefits also were seen in a Canadian study of the decades-old gout drug. The anti-inflammatory drug colchicine — sold as Colcrys, Mitigare and in generic form — was tested in 4,745 people who recently had a heart attack. After about two years, colchicine users had a 23% lower risk of suffering a new heart attack, heart-related death, stroke, cardiac arrest or urgent need for an artery-opening procedure compared with a group given dummy pills. The benefit came mostly from preventing strokes and artery-opening procedures, and some heart doctors would rather have seen more difference in heart attacks and deaths. Colchicine is being tested in several other studies, and more evidence is needed before using it routinely to lower heart risks, Dr. L. Kristin Newby of Duke University wrote in a commentary published with the study in the New England Journal of Medicine. Dr. Donald Lloyd-Jones, a Northwestern University cardiologist and program chief for the heart conference, was more supportive. “When you have a safe drug that’s easily available, it’s going to be hard to hold this one back,” he said. ___ Marilynn Marchione can be followed on Twitter at http://twitter.com/MMarchioneAP ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
[EX A]: New, old drugs may offer fresh ways to fight heart disease.

[EX Q]: The case is the first in sub-Saharan Africa. Authorities fear the virus could spread quickly in a region where health systems are already overburdened with cases of malaria, measles, Ebola and other infectious diseases. Lagos, with 20 million people, is the biggest city in Nigeria, Africa’s most populous country. The West African country, with a population of some 200 million people, has a  shortage of doctors and hospitals are often poorly maintained. The Italian man works for cement company Lafarge Africa Plc  (WAPCO.LG) in the southwestern state of Ogun, the company said in a statement. It said it had identified people who had “direct contact” with him before carrying out “isolation, quarantine and disinfection protocol.”   The Ogun state governor, in a separate media briefing, said 28 people had been placed in quarantine by the company the man worked for, although he did not mention it by name. The case has prompted a scramble by Nigerian authorities to try to “meet and observe” all passengers who arrived on the same flight as the man and to identify the places he visited before being hospitalized. “We have started working to identify all the contacts of the person since he entered Nigeria and even those who were with him on the aircraft,” Health Minister Osagie Ehanire told reporters on Friday in the capital, Abuja. The Italian, whose country has been hit harder hit by the virus than any other in Europe, arrived on Feb. 24 on a Turkish Airlines flight that had a connection in Istanbul, said Lagos state commissioner for health, Akin Abayomi. After spending the night in a hotel near the airport, he went on Feb. 25 to his place of work in neighboring Ogun state, and stayed there until he developed a fever and body aches on the afternoon of Feb. 26, Abayomi told a news conference. He was then transferred to a high containment facility in Yaba, Lagos state. Ehanire said the infection was confirmed on Feb. 27 by the Virology Laboratory of the Lagos University Teaching Hospital, and that the man was now quarantined and doing well. Turkish Airlines did not immediately comment on the case. There are no confirmed cases in Turkey. Nigerian stocks fell 1.63% to their lowest level in two months on Friday following the announcement of the coronavirus case. The spread of the new coronavirus from China has hit global financial markets, and Nigeria’s economy is at risk from the tumbling price of oil, which accounts for 90% of its foreign exchange earnings. The latest World Health Organization figures indicate over 82,000 people have been infected, with over 2,700 deaths in China and 57 deaths in 46 other countries. Officials from the Nigeria Centre for Disease Control (NCDC) are heading to Lagos to help address the case, and have activated its national Emergency Operations Centre. International health organization said they were working alongside their Nigerian counterparts. Africa Centres for Disease Control and Prevention (Africa CDC) said it is in contact with NCDC and is working with the WHO and other partners to support the Nigerian government’s response. In a statement it said it had deployed one epidemiologist to Nigeria to support assessment and response to the outbreak, and has shipped 1,000 COVID-19 laboratory test kits to the country. And the WHO, which has said it already has experts in Nigeria, has identified Nigeria as one of 13 “high priority” countries in Africa. Dr Mike Ryan, executive director of WHO’s emergencies program, told a Geneva news conference on Friday that Nigeria had “well-tested mechanisms for dangerous pathogens.”  He said Nigeria was able to utilize a laboratory network that had been developed to handle cases of Lassa fever, monkeypox and influenza. Schools and offices in Lagos provided hand sanitizer to people entering buildings on Friday. “There’s a run on suppliers at the moment for hand sanitizer and masks,” said Andrew Garza, chief operating officer of Lifestores Healthcare, a Lagos-based health technology company that provides inventory services to local pharmacies. Garza said some stockists had sold out of hand sanitizer.
[EX A]:
Italian with coronavirus in Nigeria was not isolated for almost 48 hours.